Karendia home banner

One move can change the

outcome

For your patients with CKD associated
with T2D, intervene now to deliver
dual cardiorenal risk reduction

Meet a patient
    Indications
    expand_less

    Indication 1 : CKD (Chronic Kidney Disease) associated with Type 2 Diabetes

    KerendiaTM  is indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

    Indication 2: Heart Failure (LVEF ≥40%)

    KerendiaTM is indicated to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adult patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

    References
    expand_less
    • 1
      Kerendia Prescribing Information, India 2023.